Charles D. Blanke - Researcher Profile

Publications

2 shown

Efficacy and Safety of Imatinib Mesylate in Advanced Gastrointestinal Stromal Tumors

George D. Demetri , Margaret von Mehren , Charles D. Blanke +18 more

Imatinib induced a sustained objective response in more than half of patients with an advanced unresectable or metastatic gastrointestinal stromal tumor. Inhibition of the KIT s...

2002 New England Journal of Medicine 4336 citations

Kinase Mutations and Imatinib Response in Patients With Metastatic Gastrointestinal Stromal Tumor

Michael C. Heinrich , Christopher L. Corless , George D. Demetri +15 more

Purpose: Most gastrointestinal stromal tumors (GISTs) express constitutively activated mutant isoforms of KIT or kinase platelet-derived growth factor receptor alpha (PDGFRA) th...

2003 Journal of Clinical Oncology 2275 citations

Frequent Co-Authors

Researcher Info

h-index: 2
Publications: 2
Citations: 6,611
Institution: Oregon Health & Science University

External Links

Google Scholar

Impact Metrics

h-index 2

h-index: Number of publications with at least h citations each.